Chromatin/Epigenetics
Chromatin/Epigenetics(染色质/表观遗传学)
Epigenetics
Epigenetics means above genetics. It determines how much and whether a gene is expressed without changing DNA sequences. Epigenetic regulations include, 1. DNA methylation: the addition of methyl group to DNA, converting cytosine to 5-methylcytosine, mostly at CpG sites; 2. Histone modifications: posttranslational modificationEpigeneticss of histone proteins including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation; 3. miRNAs: non-coding microRNA downregulating gene expression; 4. Prions: infectious proteins viewed as epigenetic agents capable of inducing a phenotype without changing the genome.
- Bromodomain(50)
- Aurora Kinase(63)
- DNA Methyltransferase(35)
- HDAC(210)
- Histone Acetyltransferases(78)
- Histone Demethylases(110)
- Histone Methyltransferase(240)
- HIF(102)
- JAK(173)
- MBT Domains(1)
- PARP(122)
- Pim(32)
- Protein Ser/Thr Phosphatases(34)
- RNA Polymerase(7)
- Sirtuin(77)
- Sphingosine Kinase-2(1)
- Polycomb repressive complex(2)
- SUMOylation(3)
- PAD(21)
- Epigenetic Reader Domain(246)
- MicroRNA(24)
- Protein Arginine Deiminase(7)
- Chromodomain(1)
- Citrullination(20)
- DNA/RNA Demethylation(2)
- DNA/RNA Methylation(8)
- Histone Deacetylation(44)
- Histones/Histone Peptides(62)
- PHD Domains(1)
- Tandem Tudor & Tudor-like Domains(1)
- PRMT(2)
- Readers(1)
- Small Interfering RNA (siRNA)(1)
- METTL3(2)
- WDR5(1)
- TET Protein(2)
- HuR(1)
- SF3B1(1)
Chromatin/Epigenetics 相关产品(1617)
- GC16299BET bromodomain inhibitorCAS: 1380087-89-7纯度: >99.50%
BET 溴结构域抑制剂是从专利 WO/2015/153871A2 化合物实施例 11 中提取的一种有效的 BET 抑制剂。
- GC16378TC-A 2317 hydrochlorideCAS: 1245907-03-2
TC-A 2317 hydrochloride 是一种具有口服活性的 Aurora A 激酶抑制剂 (Ki=1.2 nM)。 TC-A 2317 hydrochloride 对 Aurora B 激酶 (Ki=101 nM) 和其他 60 种激酶具有出色的选择性、良好的细胞渗透性和良好的 PK 曲线。抗肿瘤活性。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC16015 | A 366 | 1527503-11-2 | >98.00% / >97.00% | |
A 366是一种选择性的G9a/GLP组蛋白甲基转移酶抑制剂,可抑制G9a(IC 50 =3.3nM)和GLP(IC 50 =38nM)的活性。 | ||||
| GC16114 | Bizine | 1591932-50-1 | >95.00% | |
An LSD1 inhibitor | ||||
| GC16130 | C 21 | 1229236-78-5 | - | |
Protein arginine methyltransferase 1 (PRMT1) inhibitor | ||||
| GC16224 | EPZ031686 | 1808011-22-4 | >99.50% | |
EPZ031686是一种有效且具有口服活性的SMYD3抑制剂,其IC 50 值为3nM,EPZ031686能够以非竞争性方式同时抑制SAM和MEKK2,其Ki值分别约为1.2nM和1.1nM。 | ||||
| GC16261 | LLY507 | 1793053-37-8 | >98.00% | |
A SMYD2 inhibitor | ||||
| GC16277 | α-Amanitin | 23109-05-9 | >95.00% / >90.00% | |
A selective RNA polymerase II inhibitor | ||||
| GC16298 | CPI-1205 | 1621862-70-1 | - | |
EZH2抑制剂 | ||||
| GC16299 | BET bromodomain inhibitor | 1380087-89-7 | >99.50% | |
BET 溴结构域抑制剂是从专利 WO/2015/153871A2 化合物实施例 11 中提取的一种有效的 BET 抑制剂。 | ||||
| GC16314 | TC-E 5001 | 865565-29-3 | - | |
TC-E 5001 是一种 Wnt 通路抑制剂,通过新的腺苷口袋结合抑制 tankyrase 1/2 (TNKS1/2),Kd 分别为 79 nM 和 28 nM。 TC-E 5001 还抑制 Axin2 和 STF,IC50 分别为 0.709 μM 和 0.215 μM。 | ||||
| GC16378 | TC-A 2317 hydrochloride | 1245907-03-2 | - | |
TC-A 2317 hydrochloride 是一种具有口服活性的 Aurora A 激酶抑制剂 (Ki=1.2 nM)。 TC-A 2317 hydrochloride 对 Aurora B 激酶 (Ki=101 nM) 和其他 60 种激酶具有出色的选择性、良好的细胞渗透性和良好的 PK 曲线。抗肿瘤活性。 | ||||
| GC16397 | OICR-9429 | 1801787-56-3 | >99.50% | |
OICR-9429是一种有效的高亲和力的WD repeat domain 5(WDR5)抑制剂,与WDR5结合的K d 值为93±28nM。 | ||||
| GC16432 | MS023 (hydrochloride) | 2108631-19-0 | - | |
An inhibitor of type I PRMTs | ||||
| GC16436 | Tenovin-6 | 1011557-82-6 | >98.50% | |
A small molecule activator of p53 | ||||
| GC16509 | Adox | 34240-05-6 | >99.50% / >95.00% | |
An irreversible inhibitor of SAH hydrolase | ||||
| GC16519 | ENMD-2076 | 934353-76-1 | >98.00% | |
A multi-kinase inhibitor | ||||
| GC16599 | CPI-169 | 1450655-76-1 | >98.00% | |
A selective EZH2 inhibitor | ||||
| GC16611 | GW841819X | - | - | |
BET bromodomain inhibitor | ||||
| GC16614 | SCH-1473759 | 1094069-99-4 | - | |
SCH-1473759 是一种极光抑制剂,对极光 A 和 B 的 IC50 分别为 4 和 13 nM。 | ||||
| GC16638 | FG2216 | 223387-75-5 | >99.00% | |
An inhibitor of HIF-PH2 | ||||
| GC16647 | Daprodustat(GSK1278863) | 960539-70-2 | >98.00% | |
A HIF-PH1, -2, and -3 inhibitor | ||||
| GC16725 | AZ6102 | 1645286-75-4 | >99.50% | |
A TNKS1/2 inhibitor | ||||
| GC16726 | BI-7273 | 1883429-21-7 | >99.50% | |
A potent BRD9 bromodomain inhibitor | ||||
| GC16741 | UNC0379 | 1620401-82-2 | >99.50% | |
A selective SET8 inhibitor | ||||
| GC16763 | NI-57 | 1883548-89-7 | >99.50% | |
A BRPF bromodomain inhibitor | ||||
